These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25218898)

  • 1. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.
    Santarsieri M; Kumar RG; Kochanek PM; Berga S; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():15-27. PubMed ID: 25218898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome.
    Kumar RG; Diamond ML; Boles JA; Berger RP; Tisherman SA; Kochanek PM; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():253-62. PubMed ID: 25555531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.
    Santarsieri M; Niyonkuru C; McCullough EH; Dobos JA; Dixon CE; Berga SL; Wagner AK
    J Neurotrauma; 2014 Apr; 31(8):699-712. PubMed ID: 24354775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury.
    Kumar RG; Rubin JE; Berger RP; Kochanek PM; Wagner AK
    Brain Behav Immun; 2016 Mar; 53():183-193. PubMed ID: 26705843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Cortisol Profile Associations With Cognitive Impairment After Severe Traumatic Brain Injury.
    Barton DJ; Kumar RG; Schuster AA; Juengst SB; Oh BM; Wagner AK
    Neurorehabil Neural Repair; 2021 Dec; 35(12):1088-1099. PubMed ID: 34689657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.
    Lenzlinger PM; Marx A; Trentz O; Kossmann T; Morganti-Kossmann MC
    J Neuroimmunol; 2002 Jan; 122(1-2):167-74. PubMed ID: 11777556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury.
    Shiozaki T; Hayakata T; Tasaki O; Hosotubo H; Fuijita K; Mouri T; Tajima G; Kajino K; Nakae H; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2005 May; 23(5):406-10. PubMed ID: 15834305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
    Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe traumatic brain injury.
    Salonia R; Empey PE; Poloyac SM; Wisniewski SR; Klamerus M; Ozawa H; Wagner AK; Ruppel R; Bell MJ; Feldman K; Adelson PD; Clark RS; Kochanek PM
    J Neurotrauma; 2010 Oct; 27(10):1819-25. PubMed ID: 20684675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.
    Csuka E; Morganti-Kossmann MC; Lenzlinger PM; Joller H; Trentz O; Kossmann T
    J Neuroimmunol; 1999 Nov; 101(2):211-21. PubMed ID: 10580806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel Cerebrospinal Fluid and Serum Temporal Profile Assessment of Axonal Injury Biomarkers Neurofilament-Light Chain and Phosphorylated Neurofilament-Heavy Chain: Associations With Patient Outcome in Moderate-Severe Traumatic Brain Injury.
    Wang KKW; Barton DJ; McQuillan LE; Kobeissy F; Cai G; Xu H; Yang Z; Trifilio E; Williamson JB; Rubenstein R; Robertson CS; Wagner AK
    J Neurotrauma; 2024 Jul; 41(13-14):1609-1627. PubMed ID: 38588256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.
    Pleines UE; Morganti-Kossmann MC; Rancan M; Joller H; Trentz O; Kossmann T
    J Neurotrauma; 2001 May; 18(5):491-8. PubMed ID: 11393252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children.
    Newell E; Shellington DK; Simon DW; Bell MJ; Kochanek PM; Feldman K; Bayir H; Aneja RK; Carcillo JA; Clark RS
    Pediatr Crit Care Med; 2015 Jul; 16(6):549-57. PubMed ID: 25850867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery Trajectories and Long-Term Outcomes in Traumatic Brain Injury: A Secondary Analysis of the Phase 3 Citicoline Brain Injury Treatment Clinical Trial.
    Puffer RC; Yue JK; Mesley M; Billigen JB; Sharpless J; Fetzick AL; Puccio AM; Diaz-Arrastia R; Okonkwo DO
    World Neurosurg; 2019 May; 125():e909-e915. PubMed ID: 30763755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children.
    Chiaretti A; Antonelli A; Riccardi R; Genovese O; Pezzotti P; Di Rocco C; Tortorolo L; Piedimonte G
    Eur J Paediatr Neurol; 2008 May; 12(3):195-204. PubMed ID: 17881264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial Measurements of Serum Glial Fibrillary Acidic Protein in Moderate-Severe Traumatic Brain Injury: Potential Utility in Providing Insights into Secondary Insults and Long-Term Outcome.
    Robertson CS; Martinez FS; McQuillan LE; Williamson J; Lamb DG; Wang KKW; Rubenstein R; Wagner AK
    J Neurotrauma; 2024 Jan; 41(1-2):73-90. PubMed ID: 37489296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury.
    Singhal A; Baker AJ; Hare GM; Reinders FX; Schlichter LC; Moulton RJ
    J Neurotrauma; 2002 Aug; 19(8):929-37. PubMed ID: 12225653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical model of neuroinflammation in severe clinical traumatic brain injury.
    Vaughan LE; Ranganathan PR; Kumar RG; Wagner AK; Rubin JE
    J Neuroinflammation; 2018 Dec; 15(1):345. PubMed ID: 30563537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury.
    Juengst SB; Kumar RG; Failla MD; Goyal A; Wagner AK
    J Head Trauma Rehabil; 2015; 30(3):207-18. PubMed ID: 24590155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.